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The three treatment options for intracranial arteriovenous
malformation are resection, endovascular embolization,
and stereotactic radioneurosurgery. In rare cases, the mal-
formation can be eradicated using only one of these
options; most cases require a combination of the options,
even all three. The most recent advances have been in inter-
ventional neuroradiology with the introduction of high-
definition 3D imaging and hyperselective intranidal
endovascular embolization using microcatheters and
microguidewires, giving marked advantages in terms of
rapidity, efficacy, and safety. Nidal devascularization is now
much improved, as shown by the increased interval
between embolization sessions, while high-field functional
magnetic resonance imaging plays a valuable role in the
preembolization work-up and postembolization follow-up.
arious classifications have been proposed for
intracranial arteriovenous malformation (AVM),based
on specific architectonic and topographic patterns or,
more recently,on specific aspects of neurosurgical ther-
apy.
1-3 Recent technical developments in interventional
neuroradiology, in particular the high definitions now
achievable, provide a much more detailed analysis of
the anatomic and functional features of AVM, thereby




AVM is the most common congenital vascular malfor-
mation and reflects the persistence of the original com-
munication between the arterial and venous capillary net-
works. The structure of each AVM consists of afferent
arteries, a central nucleus (nidus), and a halo of dilated
efferent veins. Each element can vary in number, size,
and flow.The arterial system is mainly pial,although dural
afferents can be found at particular sites in the base of the
brain (posterior fossa). Most cases of AVM (80% and
93%) are supratentorial, mainly in the cortex and sub-
cortex.However,deep-seated or two-site lesions may be
subtentorial and, although scarcer, these are potentially
much more severe,due to the adjacent parenchyma.
AVM used to be thought infrequent (0.14% in the USA),
but more recent studies show a higher prevalence,due to
readier diagnosis by computed tomography and magnet-
ic resonance imaging (MRI).
4 Spetzler and Martin
5 pro-
posed a predictive approach to severity and treatability
based on site (with particular reference to functional areas
of encephalon), size, venous drainage (including venous
volume),and efferent blood flow.
Presentation can be differentiated into a pediatric pattern,
characterized by intracranial hemorrhage often preceded
by central nervous system abnormalities,and an adult pat-
tern of seizure or chronic headache.Although the risk of
hemorrhage is generally seen as slight,recent studies show
that it is actually at least as high as in aneurysm.
6The the-
oretical risk of cerebromeningeal hemorrhage is 2% to
3% per year, with a risk of death during rupture of 10%,
increasing after each hemorrhage.The probability of a
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Clinical researchsecond bleed is 6% in the first year, and increases by 4%
per year. Even in the absence of hemorrhage, morbidity
and mortality are higher than in individuals without AVM.
For these reasons, early diagnosis, if possible before a
hemorrhagic event,is fundamental:Brown et al found an
intracranial hemorrhage rate of 18% over a mean 8-year




There are three treatment options for AVM: resection,
stereotactic neurosurgery,and embolization or endovas-
cular surgery, alone or in sequential combination. This
multimodal approach forms the basis for defining treat-
ment objectives and planning follow-up, the aim being
the effective eradication of the AVM. The options are
complementary, and the decision to use one or another
must be flexible and informed by the clinical particular-
ities and treatment techniques available.
8 Maximum
accuracy is required in assessing the treatment objec-
tives.These include the control or eradication of persis-
tent headache, seizures, and hemorrhagic risk, and the
delay or arrest of progressive neurologic deficit.The deci-
sion process is subject to the following guidelines:
• Multidisciplinary consultation between neurosurgeons
(conventional and stereotactic) and interventional
neuroradiologists
• Definition of treatment outcome measures in terms
of the clinical presentation
•Appreciation of the gap between technical feasibility
and the target of complete cure
• Sequential implementation of treatment options
• Flexibility based on the clinical features, morphology,
and the latest developments in endovascular techniques
Objectives, procedures, and treatment sequences vary
but broadly comprise:
•Total eradication of the AVM by one of the methods
(mainly resection and embolization)
• Pretherapeutic debulking palliative embolization to
reduce arterial pedicle number,nidus size,and venous
drainage volume before resection or stereotactic neu-
rosurgery
• Clinically palliative embolization to decrease seizure
frequency and severity in massive AVM
• Palliative embolization for deep AVM fed by lenticu-
lostriate perforating arteries causing vascular steal with
progressive neurologic deficit
Hyperselective intranidal catheterization:
microcatheters and microguidewires 
Hyperselective multipedicular catheterization identifies
the afferent arteries, a variably compartmentalized
nidus, and generally dilated efferent veins (Figure 1).
However, analysis of these morphologic elements may
fail to differentiate clearly between the nidus and the
often grossly dilated veins.What is required is a hypers-
elective approach to the intranidal compartments them-
selves, since it is their destruction, with the resulting
decrease in venous flow, which is the prime target of
embolization. Using a 70-µ microguidewire (Sorcerer),
the tip of a flow-dependent microcatheter (Magic 1.2F)
can be advanced through every arterial convolution to
reach the nidus core (Figure 2). The nidal angioarchi-
tectonics can then be demonstrated in high definition
by in situ opacification, followed by the introduction of
a liquid embolus (N-butyl cyanoacrylate + iodopamidol
[Lipiodol
®]) for safe and maximally effective emboliza-
tion (Figure 3).
9,10 The aim is compartmental oblitera-
tion, in addition to reducing the number of afferent
arteries and/or narrowing their lumen,thereby decreas-
ing efferent volume and flow. The effect may be near-
immediate, but postembolization review sometimes
reveals that intranidal thrombosis is delayed for several
months.
Conclusion
Maximal accuracy is essential in the evaluation of each
AVM component.Intranidal treatment of AVM has ben-
efited greatly from the recent technical developments
in both neurovascular imaging (definition, acquisition
speed,and 3D reconstruction) and the microhardware of
endovascular intervention (microguidewire and micro-
catheter). Procedures are now faster, safer, and more
effective, with longer intervals between embolization
sessions, while pre- and postprocedural review of brain
parenchyma using functional MRI and cerebral analytic
spectroscopy has played a key role.
11,12 Further technical
advances will soon transform the quantification of man-
agement decisions, with increasingly accurate analysis
of supra- and infratentorial sites,and the ability to adapt
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Figure 1. Embolization of a huge left parietal Rolandic arteriovenous malformation. A,B:
Preembolization opacification, arrows indicate opacification by both anterior cerebral and sylvian
artery feeders. C,D: Hyperselective intranidal catheterization using a Magic 1.2 F microcatheter
(asterisk). E,F: Immediate postembolization control showing small residual vessels (arrows). G,H:
One-year follow-up after stereotaxic neurosurgery (G) using magnetic resonance angiogram con-





Figure 2. Embolization of an occiptal arteriovenous malformation with a dural fistula. A,B:
Preembolization angiogram showing the nidus of the arteriovenous malformation (arrows) opaci-
fied by the left posterior cerebral artery and the posterior meningeal artery. C,D: Hyperselective
intranidal catheterization and embolization (arrows) with an N-butyl cyanoacrylate/Lipiodol® mix-
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Figure 3. Embolization of a parietal Rolandic and occipital arteriovenous malformation. A,B: Opacification of the occipital part of the arteriovenous
malformation by left vertebral artery catheterization, demonstrating the nidus and the draining veins (arrows) and a high-flow aneurysm located in the
initial portion of the left posterior cerebral artery (arrows). C,D: Parietal Rolandic section of the arteriovenous malformation opacified by the left syl-
vian artery (main feeders) and the right and left cerebral artery (arrows). E,F: Hyperselective intranidal catheterization by a Magic 1.2 F microcatheter
and embolization with an N-butyl cyanoacrylate/Lipiodol® mixture (arrows). G,H: Three-month follow-up angiogram showing highly significant reduc-
tion of the two parts of the arteriovenous malformation and significant reduction of the high-flow aneurysm (asterisks). I,J: Demonstration of the plas-
ticity and cerebral capacity of adaptation to a specific situation in relation to a left arteriovenous malformation. Functional 3-tesla magnetic resonance
image showing activation of the left and right Rolandic motor centers with the appropriate stimulation (I). Postembolization computed tomography




Avances en el tratamiento endovascular
de las malformaciones arterio venosas
intracraneales
Las tres alternativas de tratamiento para las
malformaciones arterio venosas intracraneales
son la resección, la embolización endovascular
y la neurocirugía estereotáxica. En raros casos
la malformación puede ser erradicada utili-
zando sólo una de estas opciones; la mayoría
de las veces se requiere de una combinación
de alternativas, incluso de las tres juntas. Los
avances más recientes se han producido en la
neurorradiología intervencionista con la intro-
ducción de las imágenes en tres dimensiones
de alta definición y la embolización endovas-
cular del interior del nido, hiperselectiva, utili-
zando microcatéteres y cables microguías, lo
que produce ventajas significativas en térmi-
nos de rapidez, eficacia y seguridad. La des-
vascularización del nido está ahora más per-
feccionada, lo que se expresa en el aumento
del intervalo de tiempo entre las sesiones de
embolización. Por su parte las imágenes de
resonancia magnética funcional de alta reso-
lución juegan un papel valioso en la prepara-
ción pre-embolización y el seguimiento post-
embolización.
Progrès dans le traitement
endovasculaire des malformations
intracrâniennes artérioveineuses
Les progrès récents en neuroradiologie inter-
ventionnelle ont permis la réalisation d’abords
endovasculaires hypersélectifs et intranidaux
concernant l’étude des malformations artério-
veineuses (MAV) intracrâniennes. Trois possibi-
lités thérapeutiques demeurent envisageables
en ce qui concerne le traitement des MAV: la
microneurochirurgie classique, la chirurgie
endovasculaire ou embolisation et la radio-
neurochirurgie stéréotaxique. Si rarement, une
seule de ces méthodes peut suffire à éradiquer
totalement une malformation artérioveineuse,
le plus souvent c’est l’association de deux voire
trois de ces possibilités qui sera retenue. La
place de l’embolisation n’a cessé de se déve-
lopper et les progrès concernant l’utilisation
de microcathéters et de microguides permet-
tent un abord plus précis, plus rapide, donc
plus sécurisant pour le patient. La dévasculari-
sation nidale ainsi obtenue s’avère de meilleu-
re qualité, son efficacité doit s’apprécier dans
la durée entre deux séances d’embolisation et
l’application des techniques d’IRM  à haut
champ apparaît d’une utilité incomparable
tant dans le bilan pré-opératoire que dans le
suivi des patients.
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